FindTrial
Sign In

The effect of probiotics:Lactobacillus casei YIT 9029 (Shirota strain)for the gutmicrobiota of type 2 diabetes

The effect of probiotics:Lactobacillus casei YIT 9029 (Shirota strain)for the gutmicrobiota of type 2 diabetes - The effect of probiotics:Lactobacillus casei YIT 9029 (Shirota strain)for the gutmicrobiota of type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018246
Enrollment
70
Registered
2015-07-08
Start date
2015-02-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

With Lactobacillus casei YIT 9029 Without Lactobacillus casei YIT 9029

Sponsors

Department of Probiotics, Juntendo University
Lead Sponsor
Department of Metabolism and Endocrinology, Juntendo University, Graduate School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabetes patients with HbA1c 6.0%-7.9 %

Exclusion criteria

Exclusion criteria: 1)With liver and renal dysfunction 2)With type 1 diabetes 3)With inflammatory bowel disease 4)After the operation of gastrointestinal disease 5)BMI >=20,<=35 6)Taking alpha glucosidase inhibitor 7)Inappropriate for the study

Design outcomes

Primary

MeasureTime frame
1)The change of gutmicrobiota before and after the study 2)The change of the detection rate of gutmicrobiota in the blood before and after the study—

Countries

Japan

Contacts

Public ContactJunko Sato

Juntendo University, Graduate School of Medicine Department of Metabolism and Endocrinology

jsato@juntendo.ac.jp03-5802-1579

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026